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Jagat Narula, MD, PHD, Jason C. Kovacic, MD, PHDB ased on the coronary angiography performedmany days or even years before a patientexperienced a myocardial infarction (MI),
physicians have long believed that in the majority of
cases, culprit lesions were mild to moderate in
severity at the time they ruptured and caused MI (1–3).
The observation that coronary occlusion and MI
evolved from a mildly-stenotic coronary lesion has
left a more indelible impression on cardiology practice
than other concepts proposed in the past several
decades (4). However, contrary to these publications,
subsequent post-mortem studies of subjects dying
from cardiac arrest or acute MI indicated that the
percent luminal area stenosis at sites of thrombus
was $75% in two-thirds of cases (5), and the mean
stenosis of likely culprit lesions causing MI was >90%
(6). The angiographic studies also demonstrated that
the culprit lesion severity, although variable, was
often signiﬁcant (7,8), and that only about 10% of
culprit lesions had a diameter stenosis <50% after
thrombus removal (8). In addition, recent reports
based on serial angiography and intravascular ultra-
sound (IVUS) have clariﬁed that the early angiography
studies did not take into account the interval pro-
gression of lesion severity that may have occurred
before coronary thrombosis (3,9,10).
Intravascular imaging studies have conﬁrmed
earlier post-mortem pathologic data that plaque
rupture (PR) is the basis of acute coronary events in
the majority of cases, with the ruptured lesions
exhibiting characteristic morphological features*Editorials published in the Journal of the American College of Cardiology
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Histopathologically, the disrupted plaque usually
demonstrates substantial plaque burden and a large
necrotic core, covered by intensely inﬂamed and
attenuated ﬁbrous cap (FC) (11). The bulky plaque
may variably encroach the lumen because of the
positive remodeling (12). The high-risk plaques or
thin-cap ﬁbroatheroma (TCFA) demonstrate the same
histopathological characteristics as a disrupted pla-
que, except that the FC is still intact (13). On the
basis of these histopathological similarities, TCFA is
considered to be the precursor to plaque rupture. A
detailed analysis of the histomorphological features
(including FC thickness, percent luminal stenosis,
macrophage area, necrotic core area, and calciﬁed
plaque area) in 295 coronary atherosclerotic plaques
from patients who experienced sudden death (11)
revealed that FC thickness was the strongest single
predictor of plaque type. All stable plaques or
ﬁbroatheroma had FC thickness $85 mm, and all
TCFA and PR measured <85 mm (values rounded). FC
thickness for the majority of PR measured <55 mm,
and measured 55 to 85 mm for TCFA. TCFA with an FC
thickness of <55 mm showed lesser luminal stenosis,
i.e., <75% of the cross-sectional vessel area. These
data conﬁrmed the importance of thin FC and bulky
lesions. Importantly, a vessel area narrowing of >75%
at the lesion was found in 70% of PR and 40% of
TCFA, whereas only 5% PR and 10% TCFA had <50%
cross-sectional area narrowing. A high-resolution
imaging technique, such as optical coherence to-
mography (OCT), is necessary for the clinical assess-
ment of FC thickness. Absent the information about
FC thickness, the extent of inﬂammation and the size
of the necrotic core were the important determinants
of the high-risk plaques. Corroborating the histo-
pathological ﬁndings, the PROSPECT (Providing
Regional Observations to Study Predictors of Events
in the Coronary Tree) study (10) revealed similar
in vivo data, with the best predictive values attrib-
uted to IVUS-veriﬁed plaque burden (>70%), TCFA,
and minimal luminal area (<4.0 mm2) for the lesions
FIGURE 1 Evolution of an Atherosclerotic Plaque
Various stages of evolution in plaque morphology (during 1-year follow-up) characterized
by intravascular ultrasound demonstrate pathological intimal thickening (PIT) maturing to
thin-cap ﬁbroatheroma (TCFA) or thick-cap ﬁbroatheroma (ThCFA), and further to ﬁbrous
and ﬁbrocalciﬁc lesions. A comparison of A (proportional change) and B (actual numbers)
indicate that, even though the proportional shift may favor stabilization, the number of
unstable plaques added to the pool is equivalent to the number of plaques stabilized.
A diffuse and dynamic process emphasizes the need for aggressive medical intervention.
Inverted triangle represents no change in phenotype during follow-up. Developed from
the excellent report by Kubo et al (17).
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682likely to result in an acute event over the 3.5-year
follow-up.SEE PAGE 672In this issue of the Journal, Tian et al. (14) have
systematically analyzed the location, distribution,
and association of OCT-veriﬁed TCFA in 255 patients
who underwent 3-vessel optical imaging as a part of
an investigational data registry (14). Although thereare scientiﬁc and statistical caveats to registry data,
including selection bias, the Massachusetts General
Hospital registry remains the largest of its type, and
is a powerful tool for investigating the complex
nature of atherosclerotic coronary artery disease.
Among these patients, 643 plaques were identiﬁed
and classiﬁed into 3 groups according to stenosis
severity: 30% to 49% (Group A), 50% to 69% (Group B),
and >70% (Group C). There were far more lesions in
the less-obstructive Groups A and B (325 and 227,
respectively), than Group C (91 lesions) (see Central
Illustration of Tian et al. [14]). Among these 643
plaques, a total of 131 TCFA were identiﬁed, deﬁned
as a lesion with FC thickness <65 mm overlying a
lipid-rich plaque (maximum lipid arc >90). Two core
ﬁndings emerged from this study. First, as we might
expect, TCFA were more prevalent in the severely-
stenotic Group C (33 of 91 lesions, 36%) than in the
other groups (18%). However, because there were far
more mild to moderately-stenotic Group A or B
lesions, the absolute numbers of TCFA were highest
in Group A (n ¼ 58), intermediate in Group B (n ¼ 40),
and lowest in Group C (n ¼ 33). In addition, compared
with the other groups, lesions in Group C also had
thinner ﬁbrous caps and larger plaque burden, sug-
gestive of high-risk characteristics. This report by
Tian et al. (14), although observational in nature, can
provide substantial clues about plaque behavior.
The study supports the claim that by using OCT,
it is now possible to accurately deﬁne plaque char-
acteristics clinically, rather than, as before, only
post-mortem by histopathology (13). OCT allows
quantitation of FC thickness, which is the most
important discriminatory feature for identiﬁcation
of high-risk plaque or TCFA (11). Although imaging of
morphological characteristics of plaques has long
been possible by other modalities, such as IVUS,
they lack the resolution of OCT, although clinical-
effectiveness studies are not available for the latter
(15). Given this, and particularly as the ﬁeld moves
forward with evaluating multiple new therapies
aimed at improving plaque stability and preventing
cardiovascular events, the question arises as to
whether OCT should be the gold-standard imaging
tool for clinical studies. As an additional potential
opportunity, albeit remote, the OCT-based assess-
ment of FC thickness, plaque burden, and stenosis
severity may permit identiﬁcation of especially
worrisome lesions that may in the future be consid-
ered for targeted interventions, such as bio-
resorbable stent implantation to prevent clinical
events (16).
Atherosclerosis is a diffuse and dynamic process,
with plaques undergoing biological remodeling and
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683changes in composition. The pathological intimal
thickening (PIT) is the hub of this disease, which
evolves either into TCFA or thick-cap ﬁbroatheroma
(ThCFA) (Fig. 1). Analysis of very elegant data from
the study by Kubo et al. (17) suggests that 10% and
20% of PIT evolve as TCFA and ThCFA over 12
months, respectively. Although 75% of TCFA stabilize
over the next year, 5% of ThCFA develop high-risk
features. However, these proportional numbers are
misleading (Fig. 1A) because there are substantially
more ThCFA than TCFA, and therefore, the net
number of new TCFA produced is similar to the
number of TCFAs that stabilize (Fig. 1B). None of the
plaque characteristics, however, could predict the
likelihood of development of TCFA from PIT or
ThCFA, or vice versa. The ﬁndings of Tian et al. (14)using 3-vessel OCT imaging are in broad agreement
that there are multiple plaques across the coronary
tree, which may be at different stages of maturation.
Although signiﬁcant advances have been made in
understanding the biology of high-risk plaques, the
studies of Tian et al. (14) and Kubo et al. (17) are a
reminder that our focus must remain on the entire
atherosclerotic process and prevention of diffuse
disease, and seeking individual plaques may not be
the ultimate answer.
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